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IN VIVO GROWTH STUDIES OF HISTOPLASMA CAPSULATUM
CHAPTER I 
INTRODUCTION
Considerable work has been done on the fungus Histo­
plasma capsulatum since the discovery of the disease histo­
plasmosis by Darling in 1905 (15). This organism, being 
diphasic, has a mycelial phase when grown at room temperature 
and a yeast-like budding form when grown at about 37 C on 
certain special media, or in tissue cells of man and some 
animals (11). The yeast phase is an intracellular parasitic 
form which mostly parasitises the reticuloendothelial system, 
sometimes causing chronic progressive and systemic mycosis, 
although usually it causes an acute benign pulmonary disease 
(38, 54).
The dual form of H. capsulatum has always drawn the 
attention of workers. DeMonbreun (16), after culturing the 
organism for the first time on an artificial medium, worked 
out details of its morphological, cultural, and growth
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characteristics. He was also the first person to inject the 
organism into an animal and recover it after the death of the 
infected animal.
It is difficult to maintain the yeast phase of H. 
capsulatum since it grows very poorly and tends to convert 
into a rough mycelial form on most of the media commonly used. 
Pine (40), in his extensive study on growth requirements, re­
ported that the change of yeast into the mycelial form was 
due to three factors. First, most of the solid media contain 
agar which contains fatty acids toxic to H. capsulatum yeast 
cells. Second, H. capsulatum cells require a constant supply 
of --SH groups for a long period which is difficult to main­
tain in most solid media (46, 48). Third, there are some un­
known factors essential for smooth growth of the yeast-like 
cells which are difficult to provide in artificial media.
Whole blood has been widely incorporated into media 
for the growth of H. capsulatum yeast phase because it pro­
vides a constant supply of --SH groups and nontoxic fatty 
acids (40, 46). Several other complex media have been pro­
posed for the growth of yeast phase cells of H. capsulatum by 
different workers (29, 45, 46).
The dimorphic behavior of H. capsulatum is primarily 
controlled by environmental conditions, mainly temperature.
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humidity (34), and nutritional source. Although quite exten­
sive work has been done on nutritional requirements and de­
velopment of better culture media for this fastidious fungus, 
there still is no effective way to supply exactly the same 
conditions in artificial environments as are provided by its 
natural host.
The mouse peritoneal cavity has been widely used for 
the growth of H. capsulatum cells. Kotchner, et al. (28) in­
oculated white mice intraperitonially with mycelial suspen­
sions and showed that H. capsulatum could be converted readily 
into the yeast phase, and could be recultured on artificial 
media. Thus the mouse can be used as a tool for iji vivo 
growth of the organisms (19, 31). However, it is difficult 
to separate these organisms from tissues and blood cells since 
they spread from the peritoneal cavity and infect blood and 
internal organs. Thus due to many technical difficulties no 
quantitative study can be done on the number of cells inocu­
lated and number of cells harvested from the infected whole 
animal.
The technique of tissue culture has been employed to a 
limited extent in the study of pathogenic fungi. Baroni and 
Friedheim in 1929 first observed the effects of fungi on in 
vitro cultivated cells. Dugnes inoculated rat and chicken
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fibroblasts with different fungi and observed H, capsulatum 
intraceliularly in the fibroblasts. Howard (25) reported that 
as few as .30 yeast cells could initiate infection of the mouse 
peritoneal exudate macrophage culture. He also noticed a 
rapid conversion of mycelial phase into yeast phase in such 
exudate cells (25, 27). Larsh, et al. (.32) successfully con­
verted 13 mycelial strains to the yeast phase after seven 
transfers in tissue culture. It was found that there was a 
mass destruction of mouse peritoneal exudative cells by H. 
capsulatum, while destruction of Earl's L-strain mouse cells 
and HeLa cells was negligible.
The use of tissue culture techniques introduced a 
new effective, but expensive wdy of studying the growth of 
the yeast phase of H. capsulatum in ^  vivo-like environments. 
The diffusion chamber technique, introduced by Algire 
(2), could be another effective method of studying in vivo 
growth of H. capsulatum. The diffusion chamber is implanted 
in the mouse peritoneal cavity. The Millipore membranes on 
both sides of the chamber allow a free exchange of peritoneal 
fluid through the chamber without any entry of foreign cells 
into the chamber or exit of the yeast cells from the chamber.
Another method for ^  vivo growth of H, capsulatum is 
chicken embryo inoculation, first used by Goodpasture and
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Moore (22, 23, 36, 37). Reports from Larsh and Cozad (30) 
and Larsh, et al. (33) indicated the developing chick embryo 
as an excellent medium for conversion of mycelial phase to 
yeast phase and for recovery of the organisms. The present 
studies using chick embryo as a living medium for cultural 
studies of H. capsulatum yeast cells were based upon these 
successes.
Isolation of pathogens from nature and their study 
under defined conditions in the laboratory is essential for 
the advancement of this phase of microbiology. Investigators 
(53), however, have suggested that changes in environments 
often alter phenotype expression, affect selection, and in­
fluence genetic transfer and mutation. Hence the difference 
found between microbial behavior in a natural host and that 
in the test tube is to be expected. These differences may 
also be reflected in immunological and pathogenic properties 
of an organism.
These investigations were initiated essentially for 
two purposes. One: to work out an efficient and convenient
system of growing yeast cells of H. capsulatum in an vivo 
environment. The conditions should be as close to natural 
host as possible and the system should preferably be a closed 
one in which the organisms could be checked and recovered at
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any time for further studies. Two: to carry out a compara­
tive study of vivo grown cells recovered from this system 
with jri vitro grown cells from an artificial medium.
CHAPTER II
GROWTH STUDIES OF HISTOPLASMA CAPSULATUM IN 
THE DIFFUSION CHAMBER
The diffusion chamber technique was introduced by 
Algire and Weaver (2, 61) for culturing immunologically active 
tissue cells and has been widely used since then by different 
workers in studies of cycomorphology of soluble antibody pro­
duction (8, 18, 56), for culturing tumor cells (3) and in 
studies of modulation of peritoneal fluid cells (51),
It has been shown that the mouse peritoneal cavity or 
its exudative cells can serve as an excellent medium for the 
growth of Ho capsulatum. The diffusion chamber implanted in 
the mouse peritoneal cavity provides a simple method of grow­
ing the organisms in an in vivo-like environment. Experiments 
were carried out to study the growth of yeast cells of H. 
capsulatum in diffusion chambers, implanted in the mouse peri­
toneal cavity.. Cells grown this way were compared with in 
vitro grown cells.
Materials and Methods 
Construction of the Diffusion Chamber 
The method for construction of the diffusion chamber 
differs somewhat from that of other investigators. The cham­
ber used in this study (Belco) consisted of a rubber ring with 
the following dimensions: outside diameter, 19 mm; inside
diameter, 12 mm; thickness, 2.5 mm. A cellulose filter 
(Millipore Filter Corp.) of O.lu porosity was placed on each 
side of this ring and a flat metal ring of the same diameter 
as the rubber ring was placed upon the filter membranes on 
both sides. The whole apparatus was sealed with three, metal 
clips. These assembled chambers were placed in sterilizing 
bags and sterilized in the autoclave at 15 pounds pressure,
121 C, for 15 minutes. The chambers were used repeatedly 
after washing thoroughly and changing the filter membrane.
Filling the Chamber 
The yeast phase of H. capsulatum, Scritchfield iso­
late, was grown on Cozad’s medium (12) at 37 C for 3 days. The 
cells were harvested from the slants with cold physiological 
saline containing 0.01% cysteine. This suspension of yeast; 
cells was mixed well and filtered through several layers of 
cheese cloth. Then the cells were washed 3 times with cold
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saline, by centrifugation using International RR-2 refrig­
erated centrifuge. Washed cells were resuspended in the fol­
lowing different fluids :
1. Physiological saline (0.85% NaCl) containing 1% 
normal mouse serum.
2. Cysteine saline (Physiological saline with 0.01% 
cysteine) containing 1% normal mouse serum.
3. Tyrode's solution, TO. (Difco Labs)
4. Tyrode's solution containing 1% normal mouse serum.
5. Eagle's medium. Basal. (Microbiological Associates 
Inc. )
The total number of yeast cells in the suspension was 
checked by counting the cells in the hemocytometer counting 
chamber and the suspension was made up to the desired concen­
tration of cells (Table 1-5). Prior to the filling of the 
chamber, dilutions of the suspension were made in cold saline 
and 0.5 ml of each dilution was plated out on duplicate plates 
of Sabouraud's dextrose agar medium and Cozad's agar medium. 
All the plates were incubated at room temperature and colonies 
were counted after three weeks.
Each assembled sterile chamber was filled with 0,2 - 
0.3 ml of the test suspension just prior to implantation in 
the recipient animal. The suspension was introduced into the
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chamber through the rubber ring by means of a syringe using a 
25-27 gauge needle.
Chamber Implantation
A total of 125 normal white mice were used in this 
study. Prior to the implantation mice were anesthetized by 
injecting Nembutal intravenously. The abdominal part of the 
skin was shaved with a razor blade and then cleaned with alco­
hol. A one-half inch incision was made and the chamber was 
gently inserted aseptically into the peritoneal cavity. The 
incision was sewn with surgical gut (Ethicon Inc.). In a 
later part of the study, Autoclips (Clay Adams Inc., New York) 
also were used. For control the same procedure was followed 
except that the chambers were filled with sterile suspending 
fluid only.
Recovery and Testing of the Chambers 
Chambers were taken out by sacrificing the animal, 
disinfecting the abdominal part with alcohol, and opening the 
cavity. The chambers were recovered after 1, 2, 3, 5 and 7 
days and at the end of 2, 4, 8 and 12 weeks. The recovered 
chamber was placed in a sterile petri dish. The peritoneal 
cells were removed from outside the chamber by means of a 
brush and the chamber was washed thoroughly with sterile
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saline. The filter membrane was cut open from one side and 
the chamber fluid was removed with a Pasteur pipette. The 
inside of the chambers and the filter membranes were scraped 
and washed thoroughly with sterile saline. All the chamber 
fluids and washings were collected in a sterile 5 ml volu­
metric flask. The volume of the fluid was made up to the 5 ml 
level and mixed well.
A total count was made by removing aliquots of the 
fluid and counting in a hemocytometer. Dilutions were made 
of this harvested fluid for viability testing. Duplicate 
plates were inoculated from each appropriate dilution and in­
cubated at room temperature. The colonies were counted after 
3 weeks. The total number of cells and total number of viable 
cells for each chamber were calculated.
When clot formation occurred inside the chamber, the 
clot was treated with 0.25% trypsin solution at room tempera­
ture for 20-30 minutes or until the clot was completely dis­
solved. The trypsin digested clot suspension was centrifuged, 
the cells resuspended in sterile cysteine saline, and trans­
ferred to the volumetric flask.
Results
The results of the chamber implantation studies are 
shown in tables 1 to 5.
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Using physiological saline containing 1% normal mouse 
serum, a maximum of 1.5 times increase in the total number of 
cells was found on the third day of implantation. The viabil­
ity of the culture started decreasing very rapidly from the 
first day and by the end of two weeks it was found to be less 
than 1% (Table 1).
When cysteine saline containing 1% normal mouse serum 
was used, an increase of 1.9 times the original number of 
cells was obtained on the third day. The viability decline 
was noticed from the very first recovery (24 hours) and less 
than 1% cells were found viable by the end of the second week 
(Table 2).
The results were not much different when Tyrode's 
solution and Tyrode's solution with mouse serum were used as 
the suspending fluid. The increase in total number of cells 
was 1.7 times on the 7th day in Tyrode's solution, and 2.6 
times on the 7th day in Tyrode's solution containing mouse 
serum. The decrease in viability was still abrupt. The vi­
ability reached about one percent at the end of the 3rd week 
when Tyrode's solution was used, but when mouse serum was in­
corporated with it, about 2% cells were found viable up to the 
end of the 4th week. However, viable cells (as many as 100 
cells/chamber) were recovered after 12 weeks of implantation
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(Tables 3 and 4).
Eagle's medium supported the growth of the organisms 
somewhat better than the other suspending fluids. A maximum 
of 4.5 times increase in the original number of cells was ob­
tained on the 5th day. The decrease in percent viability 
followed the previous pattern and was lower than 1% by the end 
of the 3rd week (Table 5).
It was found that the yeast cells tend to clump to­
gether inside the chamber and this made it difficult to deter­
mine a total count. To avoid discrepancy in total counts, 
each cell and not the whole clump was counted. Budding forms 
were considered as single cells. Some of the cells were found 
to be larger in size, with thick cell walls, when harvested 
3-4 weeks after implantation.
The viability counts may be affected by clot forma­
tion, because yeast cells were subjected to harsh treatment. 
Teasing the clot, treating with trypsin for a prolonged time, 
and centrifugation and washing might have affected the vi­
ability as well as total count of the cells.
Discussion
The formation of a clot in the chamber was a hindrance 
in these studies. The clot was of gelatinous character and 
sometimes it became a tough membrane difficult to tease off.
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Digestion of the clot to separate the cells was attempted 
with 0.5% E.D.T.A. (Ethylene diamine tetracetate acid, sodium 
salt). This treatment was unsatisfactory. However, 0.25% 
trypsin solution was quite effective in digestion of the clot. 
Clot formation usually started about the fifth day and clots 
were found tougher and darker in color when chambers were left 
for longer periods inside the peritoneal cavity. When chambers 
were left inside the cavity longer than five days a tough, 
thick membrane was formed around the outside of the chamber.
The increase in cell number was not very significant 
inside the chamber. Of the five suspending fluids, none showed 
any significant enhansive effect on growth of the organisms, 
or maintenance of viability as it should be in iri vivo condi­
tions. The increase was highest in Eagle's medium and lowest 
in physiological saline. The slight increase in total count 
may be explained by the fact that some of the cells, when 
placed in the chamber, were about to multiply, or that some of 
the buds grew during the incubation. As each single cell was 
counted it affected the total number of the population. Since 
Eagle's medium was richer in nutritional supply, this medium 
resulted in somewhat greater increase in total population as 
well as maintenance of viability for a longer period. The 
rapid decrease in viability may be indicative of lack of proper
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nutrition for the organisms.
The possibility of antibodies interfering with the 
growth of the organisms is very improbable. First, the mouse 
is not a very good antibody producer against Histoplasma; 
second, there is no exit of the organisms from the chamber, 
except that some of the cells may have lysed allowing cell 
proteins to diffuse out; third, according to Algire and Amos 
(2, 3) the Millipore filter acts as a partial barrier for 
antibodies.
Although the chamber technique has been used very 
successfully in culturing tissue and peritoneal cells, it was 
not greatly successful in culturing the yeast cells of H, 
capsulatum. This could be attributed to some of the following 
reasons :
Histoplasma is an intracellular parasite and since 
the chamber was cell-free, the organisms did not find suitable 
conditions to grow in the chamber fluid. This problem can 
possibly be solved by using spleen or peritoneal cells in the 
chamber, along with the yeast cells in suspending fluid.
The process of chamber implantation and the presence 
of the chamber inside the cavity caused a constant irritation 
around that area. This might have caused production by the 
body of some toxic materials harmful to the organisms.
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Clot formation could be detrimental to the growth of 
the organisms because the cells were trapped in the tough 
gelatinous material and it might have blocked the free ex­
change of the fluids. So far no technique has been developed 
to prevent this clot formation.
In this study the most significant finding was the en­
largement of the cells and the maintenance of viability of 
some of the organisms for a long period of time. It was found 
that after two weeks some of the yeast cells started increasing 
in size, and they had definite halos, or capsules, around 
their thick cell wall. It is possible that the enlarged cells 
had developed a tough cell wall, thus becoming dormant and 
remaining viable for as long as 12 weeks.
CHAPTER III
IN VIVO GROWTH STUDIES OF HISTOPLASMA CAPSULATUM 
IN THE YOLK SAC OF CHICK EMBRYO
The use of chick embryos for culturing organisms goes 
back as far as 1905 when Levaditi experimented with spirillum 
of fowls by chick embryo inoculation. The chick embryo has 
been widely used in the study of viruses since 1920 when Juan 
and Staub used it for the first time to culture avian pest 
virus.
Goodpasture (22, 23) was the first to use chick em­
bryo in the study of fungi, and showed that certain pathogenic 
fungi could multiply in it. Moore (36, 37) reported the use 
of chorioallantoic membrane of chick embryos for cultivation 
of different pathogenic fungi, including Histoplasma capsula­
tum. He used 12-14 day-old embryos and described the macro­
scopic lesions of the membrane along with reversion of certain 
fungi into the form seen in human lesions. He described the 
chick embryo technique as a more significant one, since it is 
time consuming and less expensive than the use of laboratory 
animals. Brueck and Buddingh (6) inoculated some pathogenic
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fungi, including H. capsulatum, into the yolk sac of embryo- 
nated eggs and found it a good site for their growth. Raftery 
and Hartman (43) proved that in the yolk sac the contaminating 
fungi could not grow. Later Pileggi and Sherwood (42) re­
ported that H. capsulatum disseminated after inoculation of 
yolk sac and it was possible to demonstrate organisms in the 
spleen or liver of the embryo. Larsh, Hinton and Cozad (30) 
used H. capsulatum spores for the yolk sac inoculation of 
fertile eggs and recovered organisms from 75% of the yolk 
sacs, 25% of liver, and 13% of the spleens. They reported the 
chick embryo as an excellent: medium for recovery and conver­
sion of filamentous cultures into yeast forms. Their results 
showed that: 33 C temperature was suitable for conversion of 
mycelial forms into yeast forms and the infection was not 
highly fatal to the embryos since 72% of the inoculated em­
bryos lived to the termination of the experiment. Larsh, et 
al. (33) used single-particle inoculation of H. capsulatum 
mycelial fragments and spores and reported that 8% of the em­
bryos became infected. The use of chick embryo for culturing 
H. capsulatum since then has been neglected, and no further 
report concerning studies of this type is found in the 
literature.
Vogel and Conant (59, 60) inoculated the yolk sac of
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chick embryos with arthrospores of Coccidioidis immitis and 
found it to be a good method of obtaining spherules. These 
investigators recovered the spherules by centrifugation after 
treating the harvested yolk with four parts of 10% NaCl and 
allowing it to stand overnight.
It was demonstrated by Howitt in 1930 and Chaeffer 
and Brebner in 1933 that lipoidal and some proteinaceous 
materials could be removed from saline virus extract by adding 
an equal volume of ether with little or no damage to the 
virus (10). Craigi (14) did an extensive study on the use of 
ethyl-ether-water interface effects on the separation of some 
organisms, especially rickettsiae, from yolk sac. It was 
shown that rickettsiae, like some viruses and bacteria, were 
repelled from the ethyl-ether water interface, while insoluble 
tissue or medium constituents were selectively attracted to 
the interface. When crude yolk sac preparations of rickett­
siae were shaken with ethyl-ether, a complex physical system 
was created in such a way that rickettsiae could be separated 
in almost pure form from the water layer.
This method has been used widely for the recovery of 
a variety of viruses and rickettsiae. Surprisingly, no one 
has ever tried this system for recovery of pathogens like H. 
capsulatum from the yolk sac. Possibly the large size of the
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organisms was thought to be a hindrance to separation by the 
ether-water system.
Studies were initiated for further work on the growth 
of H. capsulatum in the yolk sac and its effect on the mortal­
ity rate of the embryo, using yeast-phase cells as the inocu­
lum. An extensive investigation was also carried out to 
develop a method of separation of the yeast cells of H. 
capsulatum from infected yolk and yolk sac. These studies 
facilitated further comparative studies of vivo grown cells, 
since the organisms could be recovered from the yolk sac 
conveniently at any time.
Materials and Methods 
Preparation of Inoculum 
Histoplasma capsulatum (Elliot strain) was used 
throughout this study. The yeast phase of this fungus was 
maintained on brain heart infusion agar (Difco), to which 5% 
blood was added. The smooth yeast-like growth from this 
medium was transferred to the surface of Cozad's medium (12), 
incubated at 37 C for 3 days, and then the cells were har­
vested and washed in sterile, cold physiological saline. The 
washed cells were suspended in cold sterile saline and 40 
units of Streptomycin and 20 units of Penicillin were added 
to each ml of the suspension.
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After adjusting the total count to the desired number, 
dilutions were made from this suspension for viability count. 
One-half ml of each dilution was plated on Sabouraud's agar 
plates (2% glucose, 40 units of Streptomycin and 20 units of 
Penicillin/ml of medium). The plates were incubated at room 
temperature and colonies were counted after 3 weeks.
Inoculation of the Yolk Sac
Fertile eggs from white leghorns obtained from a 
private hatchery were used in this study. The eggs were in­
cubated at 37 C in a regulated high humidity egg incubator 
(Sears, Roebuck Co.), and were rotated every 12 hours.
After 5 to 6 days incubation, the eggs were candled, 
and the dead embryos were discarded. The surviving embryos 
were used for the inoculation. A total of 2,140 embryonated 
eggs were used in this study. The egg shell over the air sac 
was disinfected with tincture of iodine, and a hole was made 
in the center by means of a thumbtack. The egg shell around 
the puncture was once again disinfected and then the test 
suspension was inoculated into the yolk sac with a syrine, 
using a 20-gauge 1%-inch needle. In most of the experiments 
different dilutions of H. capsulatum yeast cells were used as 
the inoculum, except in preliminary studies where a few
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batches of eggs were inoculated with mycelial suspensions. 
Each embryonated egg received 0.5 ml of the test suspension. 
After inoculation the site was again wiped with tincture of 
iodine, and the hole was sealed with melted vaspar. Airplane 
glue was also used but was found lethal to the embryo. The 
inoculation was done under the inoculation hood to reduce 
possible contamination.
The inoculated eggs were re incubated at the same 
temperature and humidity. In the preliminary work some of 
the inoculated eggs were incubated at 33 C in a regular in­
cubator with a pan of water and a blower for regulated high 
humidity. The eggs were checked after 3, 5, 7, 10, 12, and 
14 days of inoculation, and number of embryos dead at each 
interval was recorded. The dead embryos were discarded or 
checked for the presence of yeast cells by making direct 
yolk sac smears. Control eggs were inoculated with sterile 
saline and checked at the same intervals.
Harvesting the Yolk and Yolk Sac
At different intervals the yolk and yolk sac were 
harvested by the following method. The egg shell around the 
air sac was cleaned with alcohol and the shell was removed 
around the air sac. The whole egg contents were enq>tied into
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a sterile petrl dish. Care was taken not to break the yolk 
sac. The yolk sac was carefully separated from the egg white 
and the embryo and lifted out intact with the yolk and placed 
in a sterile Omni mixer cup (Ivan Sorvall Inc., Norwalk, 
Conn.). The harvested yolk sacs, along with the yolks, were 
weighed and the weight of yolk-yolk sac/egg was determined. 
Sterile saline was added to make a final 1:20 dilution (w/v) 
of yolk and yolk sac. This suspension was ground using the 
Omni mixer.
At first, different speeds and timings of the grinding 
were tried. It was found that destruction of some of the 
yeast cells occurred at high speeds and longer times. A speed 
of 8,000 rpm for 5-10 minutes was found to be satisfactory. 
With longer incubation periods a longer grinding time was re­
quired because the yolk sac became tough and granulated. The 
suspension of yolk and yolk sac thus obtained was used for 
making dilutions for viability determinations. One-half ml of 
each dilution was plated out on Sabouraud's agar plates sup­
plemented with antibiotics. The plates were incubated at 
room temperature and colonies were counted after 3 weeks. 
Smears also were made from the harvested yolk sac and were 
stained by crystal violet method described below.
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Staining of the Smears
Thin smears were made from the infected yolk sacs, 
along with some yolk, by teasing the yolk sac and smearing on 
the slide. The smear was air dried and fixed in absolute 
alcohol for 15 minutes. The following different staining pro­
cedures were tried for staining the fixed smears : Gram
staining, Giemsa staining, Wright's staining, and Methanamine 
silver staining.
Since the above mentioned staining methods did not 
provide good results, a special staining method was developed. 
The fixed smear was oxidized by leaving the slide in 5% 
chromic acid solution for about one hour. The slide was washed 
in distilled water for 5 minutes and then immediately stained 
with Gram's crystal violet for 1-2 minutes depending on the 
thickness of the smear.
Yolk Sac Passages of H. capsulatum
H. capsulatum yeast cell passages in yolk sac were 
performed by harvesting the infected yolk and yolk sac after 
5-6 days of inoculation, making a 1:2 suspension of it and 
reinoculating a fresh batch of 5-6 day-old embryonated eggs. 
Penicillin (20 units/ml) and Streptomycin (40 units/ml) were 
added to the yolk-yolk sac suspension prior to inoculation
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and 0.5 ml of the suspension was Inoculated into each egg.
Six days after the second passage the yolks and yolk sacs 
were harvested and the organisms were recovered.
Harvesting the Organisms from the 
Yolk and Yolk Sac
At first trypsin enzyme was tried to free the yeast 
cells from the yolk sac. Later the ethyl-ether-water inter­
face system which has been used for separation of viruses 
and rickettsiae was attempted, and this proved to be the 
method of choice. After some modifications a successful pro­
cedure was adopted to separate the yeast cells from the yolk 
and yolk sac. A complete procedure of harvesting the organ­
isms is outlined in the flow diagram.
Morphological Studies of ^  vivo 
Grown Cells
Smears which were prepared from the infected yolk 
sacs were stained with the special method of staining. A 
total of 100 cells were measured for each 5, 10, and 14 day 
period. In two batches, a few infected eggs were allowed to 
hatch, and the yolk sacs from the hatched chickens were re­
moved (17 days after inoculation). Smears were made and cells 
were measured.
Wet mounts were made from the yeast cell suspension
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Flow Diagram 1. Method of Harvesting the Yeast Cells of
Histoplasma capsulatum from Infected Yolk 
and Yolk Sac
Empty the whole egg content in a sterile petri dish,
Remove yolk and yolk sac and place in a beaker. 
(Streak Sabourand’s agar plates, make smears)
Add 4 volumes of 0.5% formalized saline 
(Physiological saline containing formalin),
Mix well, leave for 2-3 days at 5 C
O
Filter through cheese cloth.
t2
Filterate-yolk suspension Yolk sac.
Add 10% NaCl (W/V), Add 0.5% formalized saline.
Mix well, leave at room grind in Omni mixer (8000
temperature for 24-48 rpm for 30 minutes under
hours. the hood). Add formalized
saline to make about 10% 
suspension, leave for 24- 




Centrifuge at about 8000Xg for 30 minutes.
Discard the supernatant.
Suspend sediment in 0.2% formalized saline 
(Omni mixer, 8000 rpm, 2-3 minutes).




Suspend sediment in O.lM Phosphate buffer pH 6-7. 
(Omni mixer SOOOrpm, 2-3 minutes.)
Centrifuge SOOO^g, 30 minutes.
Discard si^ematant.
Resuspend sediment in Phosphate buffer.
(Omni mixer)
Centrifuge 8000 Xg, 30 minutes.
Discard supernatant.
Suspend sediment in Citric a^id-phosphate or Acetic acid- 
acetate buffer, O.lM, pH 4.5 
(Omni mixer 8000 rpm, 2-3 minutes).
Centrifuge 8000^g, 30 minutes.
Discard supernatant.
Resuspend in the same^uffer (Omni mixer) .
Make a 3-4% suspension.
Add % volume of ethyl ether (anhydrous) with the 







Allow to stand for 15-20 
minutes.
Interface and ether layer.
Add % volume buffer.
Shake 10-15 minutes.
Allow to stand for 15 minutes.
Interface and ether layer.
Add % volume buffer and % 
volume ether.
Shake vigorously for 5 minutes 
Allow to stand for 15 minutes.
2 Remove the 
aqueous portion
Add % volume ethyl ether.
Shake vigorously for 5 minutes. 
Allow to stand for 15-30 minutes
O
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Collect the aqueous portion.
O  ■
Bubble air through this suspension at 
37 C to eliminate ether.
Leave overnight in refrigerator.
Centrifuge at 12100 Xg for 30 minutes.
t2
Sediment
Suspend in physiological 
saline.
Supernatant
Filter through millipore 
filter (0.45^ porosity), 
discard the filtrate.
Suspend the residue in 
physiological saline. in 12Add preservative
Count the cells and make the suspension 
according to desired concentration.
29
obtained from ether separation, and 100 cells were measured 
for each incubation period of 5 days, 5 days following 2 
passages, and 10 days.
As a control, a yeast culture of H. capsulatum, grown 
at 37 C on brain heart infusion blood agar slant, was har­
vested after 3, 5, 10, 14, and 17 days of incubation. The 
cells were suspended and killed in 0.5% formal saline, washed 
2 times, suspended in citrate buffer (pH 4.3) and then were 
shaken for 5 minutes with an equal volume of ethyl ether.
The water layer was removed and the treatment was repeated 
once more. The resulting aquous suspension was centrifuged 
and the sedimented yeast cells were resuspended in physio­
logical saline. Wet mounts of these preparations were used 
for size measurements.
A lOOx oil immersion objective and a lOx ocular 
equipped with micrometer were used in all measurement studies. 
The ocular micrometer was calibrated in microns with a standard 
stage micrometer.
To avoid bias in measurements, the slide was moved 
longitudinally on the microscope stage and any cell which 
superimposed the ocular micrometer was measured. Exception­
ally large cells, if seen in the field out of reach of the 
micrometer axis, were measured separately.
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Animal Inoculation
Antigens : The following different antigens were
used for the immunological studies.
1) formalin killed H. capsulatum yeast cells, grown 
in vitro for 3 days at 37 C.
2) Same as above but treated with ethyl-ether.
3) H. capsulatum, grown iji vivo, harvested after 5 
days of yolk sac inoculation by ether-water interface 
system.
4) Same as above but harvested after 10 days of 
inoculation.
5) Same as above but harvested after 5 days of the 
second passage.
6) 2% suspension of infected yolk and yolk sac har­
vested after 10 days of inoculation (no ether 
extraction).
7) Control. 2% suspension of yolk and yolk sac of a 
16-day-old embryonated normal egg.
Animals : 22 white leghorn hens, 4-6 months old were
used. The chickens were obtained from a private farm in Okla­
homa. Three chickens were used for each of the seven anti­
gens and one chicken was used as the animal control. The 
chickens were bled by heart puncture prior to the first
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injection, and at weekly intervals after each injection.
Each chicken received a total of four intravenous injections 
into the wing vein, each injection one week apart and contain­
ing 1 X 10® cells/kilogram body weight. In the case of anti- 
gent 6 and 7, 1 ml/kilogram body weight was given. The blood 
samples were allowed to stand at room temperature and then 
centrifuged to separate the serum. All the sera were frozen.
Serological Studies
Capillary Tube Agglutination (CTA)
Antigen for CTA was prepared according to the pro­
cedure described by Cozad and Larsh (13) . Two different con­
centrations of antigen, 25% transmission and 35% transmission 
at 5900 A (Bausch and Lomb Spectronic '20') were used. Sera 
were diluted two fold up to 1:2048 dilution in physiological 
saline and were tested against the antigen for CTA. In the 
latter part of the study higher salt concentrations of the 
diluent were also tried. Some test samples were heated at 
50 C for 30 and 60 minutes and others were heated at 60 C for 
30 minutes. These heat treated sera were again checked by 
the capillary tube agglutination test.
Tube Agglutination
Testing the Chicken Sera. The procedure for the
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agglutination test described by Cozad (12) was followed. I"wo 
fold dilutions of the test sera were made in such a way that 
each tube contained 0.5 ml quantity. To each tube 0.5 ml of 
the yeast cell antigen was added. The tubes were incubated 
at the following temperatures and times, and then centrifuged 
at 2400 rpm for 7 minutes (Int. centrifuge no. 1).
25 C for 2 hours   centrifuge
25 C for 2 hours; 5 C overnight ----  centrifuge
37 C for 2 hours ----  centrifuge
37 C for 6 hours ---- centrifuge
Readings were made by gently tapping the bottom of the tubes.
Tube Agglutination
Testing the Antigens. Different antigens, vivo 
and vitro grown, were tested against known positive anti 
H, capsulatum rabbit serum (CTA titer 1:1024). Dilutions of
1:300, 1:500, 1:1000 and 1:2000 of in vitro grown yeast cells
were made. The cell counts in these dilutions were deter­
mined and dilutions of ̂  vivo grown cells were made in such 
a way that each dilution would have the same number of cells 
as the corresponding suspension of in vitro grown cells. The
rabbit antiserum was serially diluted two fold in physiological
saline in 0.5 ml quantities. To each serum dilution 0.5 ml 
of the test antigen was added and the tubes were shaken
33
vigorously. The same incubation times and temperatures were 
used as in the previous experiment.
Precipitation Tests
Agar Gel Precipitation. The Ouchterlony plate method 
was employed. Seven tenths to 1% agar was used in the plates. 
Two concentrations (5X and lOX) from two different batches of 
histoplasmin were used. The plates were incubated at 5 C,
25 C, and 37 C for two weeks.
The micro Ouchterlony method (20) also was tried.
Two concentrations of histoplasmin (5X, lOX) were used as the 
antigen. Salt concentrations of 0.85%, 1.7%, 5%, 8%, and 10% 
were used in the agar. It was found that in higher salt con­
centrations agar should be melted first before the addition 
of the salt; otherwise, the agar would not go into solution. 
The slides were left at room temperature in a humidity cham­
ber and were checked for up to two weeks for the presence of 
precipitation bands.
Immunoelectrophoresis ; The method described by Adam­
son and Cozad (1) was followed. Two concentrations (5X and 
lOX) from two different batches of histoplasmin were used. 
First, histoplasmin was added to the side wells and, after 
electrophoresis, the test chicken serum was added in the cen­
ter trough.
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In another experiment the above procedure was re­
versed, i.e., electrophoresing the test serum first and then 
adding histoplasmin in the center trough.
In still another set of experiments the antigen was 
electrophoresed and the slides were immediately bathed in the 
following salt solutions for 1-4 minutes: 1.7%, 5%, 8%, 10%,
and 15%. The serum was then added to the center trough and 
allowed to diffuse. In the last set of tests the above pro­
cedure was reversed.
Capillary Precipitation
The capillary precipitation test described by Salvin 
and Furcolow (47) was adapted for checking the presence of 
antibody in the chicken sera. Histoplasmin (lOX) was used as 
an antigen. Starting with undiluted antigen for the first 
tube two fold dilutions in physiological saline were made up 
to a 1:512 dilution. The capillary tubes were incubated at 
5 C, 25 C, and 32 C for different periods of time.
In another set of experiments higher salt concentra­
tions, 1.7%, 5%, 8%, and 10%, were also used as the antigen 
diluent. Some of the capillary tubes were incubated as long 




Histoplasmin (lOX) was diluted two fold in Durham 
tubes using saline with salt concentrations of 0.85%, 1.8%, 
5%, 8%, 10%, and 15%. Equal quantities of undiluted serum 
were layered on top of the antigen. The tubes were left at 
room temperature and precipitation bands were checked at 
different intervals.
Results and Discussion
The results of preliminary studies on the effect of 
incubation temperature on H. capsulatum cells in the embryo­
nated egg disagree with the findings of some previous workers 
(30, 33) who reported 33 C as optimum temperature for the 
growth of yeast phase in the yolk sac. It was found in this 
study that when yeast cells were inoculated into the yolk sac 
and the eggs were incubated at 33 C, the cells had a tendency 
to convert into the mycelial form. Chain formation and short 
mycelia were observed on the slides made from infected yolk 
sac at different intervals. When the mycelial suspension was 
used as inoculum, the results were the same. A mixed popula­
tion of yeast cells and mycelial fragments were obtained. 
However, eggs which were incubated at 37 C had perfect yeast 
phase, and no mycelial fragments were observed.
Difficulties arose in staining the smears made from
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the infected yolk sac. Most of the staining methods provided 
poor results because of the thickness of the smear and the 
presence of lipoidal material from the yolk. The nuclei of 
the chicken red blood cells were sometimes difficult to dif­
ferentiate from the yeast cells. The special staining method 
using crystal violet after oxidizing the smear with chromic 
acid was found quite satisfactory. By this method the cyto­
plasm of the cell took an uneven stain, but the cell wall was 
stained very prominently, revealing a very distinct halo 
around it.
Effect of Dose of Inoculum on the 
Death Rate of Embryo
Table 6 shows the effect of size of H. capsulatum 
yeast cell inoculum on mortality rate of the embryos. As 
indicated by Figs. 1 and 2, the death rate of the embryos 
after inoculation was proportional to the number of organisms 
inoculated. The death rate was found to be quite variable in 
different batches of embryos receiving the same dose. When 
an average was estimated it was found that most of the embryos 
died 5 to 7 days after the inoculation. Figure 1 indicates 
that at higher doses the peak mortality rate was on the 5th 
day. However, upon decreasing the number of organisms in the 
inoculum the peak shifted toward the 7th and 10th day. Figure
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2 indicates accumulative percentage of dead embryos at dif­
ferent intervals. The percentage of embryos hatched in each 
case is also shown in Figure 1. The number of embryos hatched 
increased as the inoculum was decreased.
The lethal effect of H. capsulatum on the chicken 
embryo has not been reported by previous workers. Welsh 
and Guidary (64) reported a study on the infection of 
chorioallantoic membrane of chicken embryos by H. capsulatum. 
They observed reactive plaques and ulcerative lesions. The 
plaques consisted of extracellular yeasts overlying a non­
ulcerated area of reactive ectoderm. They found that the in­
fection was not progressive, and peaked on the 5th day, fol­
lowed by abrupt subsidence with degeneration of intracellular 
yeast and ultimate calcification and return of the membrane 
to normal thickness by the 12th day. They suggested an im­
mune response as a possible explanation for the self-limited 
infection. The feasibility of antibodies overcoming infection 
during the developing stage seems improbable due to lack of 
immune response in chick embryo (7). Moreover, according to 
this report infection was not progressive, but, on the con­
trary, positive cultures were obtained almost every time in 
this study when liver and spleen of the embryo from an in­
fected egg were plated. These findings and the findings of
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previous workers (30) indicate that the infection in an 
embryonated egg is not localized and yeast cells can be ob­
tained from almost any part of the embryo or the egg. Very 
recently Guidary and Spence (24) observed yeast cells in the 
subcutaneous tissue and feathers of inoculated embryo which 
also indicates a generalized infection.
Considering these facts, it can be stated that the 
death of chick embryos was due to the infection by H. capsula­
tum. On the contrary, according to some reports (35, 50), 
adult chickens are immune to Histoplasma infection and the 
organisms are destroyed in the tissues as soon as they enter 
into the body. Although H. capsulatum has been frequently 
isolated from chicken manure which gives an indication that 
chickens may be associated in some way with this fungus, 
search for H. capsulatum in chickens has been unsuccessful. 
Skin testing by Menges (35) showed negligible positive re­
sults . A thorough study of normal chicken guts (50) showed 
no trace of these organisms. So far experimental infection 
of chickens with Histoplasma has been unsuccessful (35, 50),
In a recent report Guidary and Spence (24) reviewed the work 
of Tewari and Cançbell (55) for histologic and cultural evi­
dence of association of chickens with H. capsulatum, and the 
isolation of H. capsulatum from a feather pillow by Campbell,
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Hill, and Falgout (9). On the basis of these reports and 
their own work they supported the working hypothesis that 
maintenance of H. capsulatum in nature might involve passage 
of the fungus through chicken with the feather pulp as the 
portal of exit.
The other possible reason for the death of embryo be­
sides infection could be the toxicity of the organisms growing 
inside the egg. There was considerable growth and increase 
in the cell number, and during this growth toxic materials 
deleterious to the chicken embryo may be produced.
Viability of the Organisms Inside the Egg 
at Different Periods of Incubation
Variable results were obtained when whole yolk sac 
along with the yolk was harvested, ground, and its dilutions 
plated. It was found that different numbers of viable cells 
could be obtained from different batches of eggs inoculated 
with the same dose. When an average was calculated, it was 
found that the maximum number of viable cells could be ob­
tained around 5-7 days after inoculation. Table 7 shows the 
average number of viable cells obtained at 3, 5, 7, 10, and 
14 days after inoculation. A growth curve was obtained when 
the log of the total number of viable cells harvested was 
plotted against time of incubation (Fig. 3). This curve
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shows a gradual rise until the peak is obtained on the 7th 
day. This part of the curve can be compared with the log or 
exponential phase of a typical bacterial growth curve. After 
7 days there was a sudden decrease up to 10 days followed by 
a slower decrease. This portion is comparable to the station­
ary phase of a typical bacterial growth curve. In a recent 
report by Reca and Campbell (43), it was showm that when the 
yeast phase of H. capsulatum was grown on a synthetic medium, 
an increase in the number of viable cells was obtained up to 
the 4th day of incubation, after which there was a marked de­
crease in the number of new cells. When growth was followed 
by optical density determinations, the exponential phase ex­
tended up to the 6th day, after which the stationary phase 
started. The difference in the growth curve reported by 
these workers and the growth curve obtained in this study is 
probably due to differences in cultural conditions. Reca and 
Campbell (43) used a liquid medium (in vitro), while in these 
studies the cells were grown under ^  vivo conditions.
The use of a larger number of eggs and more frequent 
checking on the viability of the organisms in the eggs would 
possibly give better results for satisfactory statistical 
analysis.
A problem was encountered in this study when the yolk
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sac was ground in the Omni mixer- Due to the high speed of 
the Omni mixer blades and agitation of the suspension, de­
struction of the yeast cells was inevitable. The consistency 
of the yolk sac changed on prolonged incubation and some­
times the yolk was found to be tough, requiring higher speed 
for making an even emulsion- This might have influenced the 
viability of the cells. In this study only yolks and yolk 
sacs were checked for the viability studies. The yeast cells 
were also disseminated in the embryo and checking different 
parts of eggs and embryos may possibly give a somewhat differ­
ent picture in regard to the increase in cell numbers.
It was found that when dilutions of the ground yolk- 
yolk sac suspension were plated out on brain heart infusion 
blood agar and incubated at 37 C, yeast colonies were ob­
tained- The number of yeast colonies obtained was the same 
and sometimes greater than the number of mycelial colonies 
obtained on Sabouraud's agar plates at the same dilution.
These yeast colonies probably appeared because the yolk and 
egg proteins were present in the diluted suspension in suf­
ficient quantity to supplement brain heart infusion blood 
agar medium for the support of yeast phase growth.
Prolonged viability of the organisms in the frozen 
yolk and yolk sac was another significant observation. When
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yolks and yolk sacs, frozen at -20 C for as long as one year, 
were checked, viable cells were found which grew very well on 
Sabouraud's agar plates.
Harvesting of the Cells
Separating the yeast cells of H. capsulatum from the 
yolk and yolk sac was one of the most difficult problems in 
this study. An attempt was made to use trypsin for digestion 
of the yolk sac tissues. The organisms could be separated to 
some extent by the use of higher than 0.25% trypsin solution 
for prolonged treatment, but this treatment ruptured the cell 
wall of the organisms. Moreover, cells present in the yolk 
material still could not be separated by this method.
Other physio-chemical methods were attempted to find 
a suitable procedure for separation of the organisms. In a 
preliminary study an ethyl-ether-water separation system was 
found promising. Different methods of ethyl-ether-water 
separation as reported by Craigie (14) were investigated for 
this separation. The efficiency of the method in separation 
of the cells from suspension was found to be dependent on 
the following factors :
a) Nature and concentration of the buffer system: 
Different buffers like citric acid-phosphate buffer, 
acetate-acetic acid buffer, and phosphate buffer
43
were tried with molarities varying from 0.1 to 0.5.
b) Hydrogen ion concentration: This effected the
development and separation of the emulsion from the 
aqueous portion. Buffers of varying pH from 3 to 8 
were used.
c) Quantity of the buffer and the test suspension: 
Change in quantity of either component controlled 
the interface and aqueous layer development.
After working with the above variables, a procedure 
was adopted which resulted in the best yield of organisms 
from yolk-yolk sac suspensions (Flow diagram-1).
The main problem in this separation was the presence 
of small egg protein particles which adhered to the yeast 
cells in the final harvested suspension. The association of 
yeast cells with the particles was so strong that they could 
not be separated by centrifugation. The harvested suspension 
was shaken with phosphate buffers of varying pH. It was ob­
served that O.lM phosphate buffer at pH 6-7 facilitated the 
separation of the organisms from the egg protein.
Results obtained from the use of citric acid-phosphate 
buffer and from acetic acid-acetate buffer (O.lM) were almost 
the same and either one of these two buffers could be used in 
this separation. The pH, however, was very critical and best
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results were obtained at pH 4.5.
It was noticed that a better yield was obtained if 
fresh yolk-yolk sac were used in comparison with the frozen 
one. Moreover, better yields were obtained if yolk was 
separated from the yolk sac and both were treated separately. 
The separated yolk was treated with high 10% salt, as sug­
gested by Vogel (60), to break down some of the yolk proteins. 
After high salt treatment the yolk lost its viscosity and the 
yolk material was eliminated to a certain extent by centrifu­
gation.
Some of the egg material was always present with the 
harvested yeast cell suspension, although a second shaking of 
this suspension with % volume ether helped in removal of some 
of these undesirable particles. A pure suspension of H. 
capsulaturn yeast cells free of contaminating egg materials 
could not be obtained.
When the interface which was supposed to contain egg 
proteins and tissue cells was checked microscopically, numer­
ous yeast cells were found adhering to the protein particles. 
Some of these cells were recovered when this interface emul­
sion was shaken with an additional quantity of buffer and 
ether, but still a great number of organisms, mostly the 
larger ones, could not be recovered and were lost in the
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interface emulsion.
An accurate estimation of the total number of organ­
isms found per egg was not possible because of the loss of 
the cells during the ether harvesting process. A rough esti­
mation, however, indicated a maximum increase of 25 times the 
original number on the 10th day of inoculation.
When the cell suspension harvested by the ether-water 
system was centrifuged, it was found that some of the cells 
remained in suspension and did not spin sediment even at a 
speed as high as 10,000 rpm (12100 Xg). This was probably 
due to the light weight of the cells and also because of the 
presence of buffer at acidic pH. The only successful way to 
wash these cells was to filter the suspension through a 
Millipore filter and resuspend them in physiological saline. 
Centrifugation of the cell suspension at high speed (10,000 
rpm, 12100 Xg) followed by filtration of the supernatant, was 
found to be the most convenient and rapid method.
Cell Size at Different Intervals
One of the most significant findings in this study 
was the presence of giant yeast cells after prolonged incu­
bation of infected fertile eggs. It was found that the in­
crease in size was related to the period of incubation; the 
longer the incubation time, the greater the size of the
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organisms (Plate 1).
Table 8 shows average size of the cells and the size 
distribution at different intervals. Figure 4 indicates the 
cell size increase upon incubation. The average size of cells 
in the inoculum (3 day old culture), when measured after 
shaking the cells with ether, was 3.15p. After 5 days of in­
cubation the average cell size on blood agar (in vitro) was 
found to be 3.17ju, which is not a very significant increase. 
Cells grown in the yolk sac (in vivo) became larger with an 
average size of 3.6;u from ether harvested suspensions, and 
3.95p from stained yolk-sac smears (Fig. 5A). By the 10th 
day the increase was greater. The average control ^  vitro 
grown cell measurement (ether treated) was 3.65;u while in vivo 
grown cells harvested with ether had an average size of 4.82^. 
The average cell size measured from yolk sac stained smears 
after 10 days' incubation was 4.83;] (Fig. 5B) . Ether harvest­
ing was not done on cultures older than 10 days, but when 
smears were made from yolk-yolk sacs after 14 and 17 days of 
incubation, averages of 5.0^ and 6.0;j were obtained. The 
cell size on blood agar (after ether treatment) was 3.7)u and 
3.77;j, after 14 and 17 days' incubation, respectively. This 
shows that the increase in in vivo grown cells was signifi­
cantly higher than in in vitro grown cells. Especially in 14
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to 17 day cultures there was not much Increase in the cell 
size of in vitro grown cells while ^  vivo grown cells showed 
a tremendous increase in size. In two batches of embryos 
when the infected eggs were hatched (17 days) and the yolk 
sac was harvested, cells as large as 1 1 were observed; the 
majority of the cells were found to be in the larger size 
range (Fig. 5C, Plate 1),
The incubation period also had a great influence on 
the size distribution of the organisms (Table 8). Figures 5A, 
B, and C show the distribution of size of vitro and ^  vivo 
grown cells at 5, 10, and 17 days. Most of the cells in the 
original inoculum lie between 2-kp in diameter (long axis) 
with a very sharp and high peak in 3-<^ area. On further 
incubation (5 days. Fig. 5A) the peak begins to flatten and 
spreads out. ^  vitro grown cells are mostly in the range of
2-4;u while iji vivo grown cells are mostly in the range of
3 - ^  and the curve extends up to 6-7;u (Fig. 5A). The peak 
of the cells measured on the 10th day shifts toward a higher 
range of size (Fig. 5B). The majority of ^  vitro grown 
cells are in the range of 2-l\p but cells up to 7 - ^  are found. 
The majority of vivo grown cells measured on the 10th day 
of incubation are in the 3-5^ range, but the distribution 
curve extends up to the 12-li^ range. On the 14th day of
48
incubation after inoculation the range of cell sizes is 
greater. Jn vitro grown cells are found in the range of 2-9u 
with the majority of them in the range of 2-5p. The majority 
of the iri vivo grown cells at the same time are in the range 
of 3-6jj with the curve extending up to 12~13;li. The difference 
in In vivo and in vitro grown cell sise is more prominent on 
the 17th day. In vitro grown cells (Fig. 5C) have a wider 
peak with the majority of the cells lying in the range of 
2-5^ and the curve extends up to the 10-11^ range, while peak 
of im vivo grown cells also flattens and the curve is flatter, 
extending up to 13-1^ category. The majority of the cells 
in this case are found in the range of S-Sjp (Fig. 5C).
Some complications were encountered in the cell size 
studies due to the presence of several variables. The size 
of the cells differed among different embryos of the same age. 
Furthermore, change in size of the cell was inevitable due to 
shrinkage of cells during drying, oxidizing and staining of 
the yolk sac smear. When the cells were harvested with ether, 
the loss in the interface of cells representing the larger 
population was unavoidable. Moreover, cells which were re­
covered from the aqueous phase had undergone violent shaking 
with ether, which affects the size, A decrease of 4.5% was 
obtained in the average cell size when formalin killed m
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vitro grown cells were treated with ether, The control cells 
(in vitro grown cells) conId not be measured by simple stained 
smears on slide because the cell shrinkage and change in the 
shape of the cell was too great to be overlooked. Cells grown 
on blood agar, killed by formal saline, and shaken with ether 
were used as a control. These variables did not, however, in­
fluence the significance of the data obtained from cell size 
studies because the above mentioned variables had a shrinking 
effect on the cells and the presence of large cells would 
still be significant.
The presence of giant cells in the embryonated egg 
once again opened a controversial question concerning H. 
capsulatum and H. duboisii. "Is H. duboisii a mere morpho­
logical variation of H. capsulatum or is it a separate species?" 
(17, 49, 57, 58). H. capsulatum and H. duboisii are identical 
in the mycelial phase, grossly and microscopically. The 
primary basis of separating the two is the presence of large 
yeast cells in addition to classical small forms in H, duboisii 
infection.
In 1953 Schwarz (49) noticed giant forms of H. capsu­
latum in tissue explants. He believed that giant forms were 
simply a growth in size in the original small yeast-like cell. 
Binford (5) reported large extracellular forms of H. capsulatum
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in some necrotic tissues. Large forms have been occasionally 
observed in tissues of infected animals as well as in the 
tissues of American patients (5, 52). Drouhet and Schwarz 
(17) studied 18 strains of Histoplasma including four strains 
of H. duboisii. They observed large forms in almost all cases 
of H. capsulatum and H, duboisii. They concluded from their 
findings that "The presence of large forms in tissues of non- 
African patients and the experimental production of such forms 
indicate the great variability of the parasitic phase of H. 
capsulatum." Weed (62) also agreed with the idea that the 
dual form infection might represent just variation in size of 
Histoplasma.
Vanbreuseghem (57, 58), who originated the idea of 
separate species, infected guinea pigs with H. duboisii.
After 8-15 days the parasite looked so much like H. capsulatum 
that he named these forms the capsulatum form of H. duboisii. 
Later the organisms enlarged and he called these mature forms 
duboisii forms. Okudaria and Schwarz (39) in a later study 
reported that H. capsulatum could be differentiated from H. 
duboisii by the size in the parasitic yeast phase, by the 
difference in pathogenicity, and by particular tissue response 
in hamsters and mice. They also reported some characteristics 
of H. duboisii, mainly simultaneous occurrence of small.
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middle-sized and large forms of yeast cells in tissue, and a 
double contoured cell wall.
Pine and Drouhet (41) suggested that the ability to 
form the duboisii form varied with strain, with the experi­
mental animal and with the form of the yeast culture used in 
the inoculum. They concluded from their results that the cap­
sulatum form was a transient stage in the morphogenesis of 
the parasite. The duboisii form, once formed, reproduced only 
duboisii daughter cells, even though some of the latter might 
fall within the size range of the mature capsulatum form. The 
very large adult duboisii-like cell in necrotic tissue, ac­
cording to Pine, represented a terminal phase of growth.
These cells, which sometimes had a multi-layered thick wall, 
were probably a degenerated form (41).
Although most of the workers have agreed that H. 
duboisii can be differentiated from H. capsulatum on the 
basis of cell size and thus possibly can be placed as a sepa­
rate species, the presence of large cells (so-called duboisii 
form) in the yolk sac makes this concept more deceptive. It 
has been claimed that large forms of H. capsulatum are found 
in necrotic and dead tissues or in i£ vitro conditions, but 
these large cells were harvested from living infected embryo­
nated eggs, the conditions of which are obviously not vitro.
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Whether the yolk sac should be considered as necrotic tissue 
is questionable.
The morphological characteristics of the large forms 
of H. capsulatum obtained from the yolk-yolk sac also were 
very conspicuous. The giant cells had a thick cell wall which 
appeared to have a double contour with a refractile halo 
around it, all of which are characteristic of H. duboisii 
(Plate 1). Some of the cells had an occasional notch in the 
capsule-like layer on the narrower side, which is also a char­
acteristic of H. duboisii, as described by Vanbreusegham (57).
At this point no definite statement can be made about 
the possible relationship of H. capsulatum and H. duboisii, 
since H. duboisii was not used in these studies. A more 
thorough study is required to reveal some of the facts about 
the large size of H. capsulatum. A study involving the use 
of H, duboisii and H. capsulatum is suggested with inoculation 
of yolk sac of chick embryo and measurement of organisms at 
different intervals for comparison. A study of the cells 
recovered from liver and spleen of the infected chick embryo 
would help also in resolving the question.
Immunological Studies
Chickens were used in this study as the test animal 
for hyperimmunization because of previous reports about high
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antibody production in this animal against certain antigens. 
Precipitin production in chickens has been extensively studied 
(4, 21, 65, 66) and titers as high as 1:32 x 10^ have been 
reported by Wolfe.
In a preliminary work three one month old chickens,
hatched from the control eggs, were bled and checked for the
CTA titer. No agglutination was observed. Later these 
chickens were immunized by giving four injections, each one 
week apart. When the serums taken after one week of the last 
injection were tested, a CTA titer of 1:256 was obtained. On 
the other hand, when infected eggs were hatched and sera of 
two of these newly hatched chickens were tested, a titer of 
1:32 was obtained by the CTA method. These findings stimu­
lated the use of chickens as the test animal.
It was found in later studies that adult normal 
chicken sera agglutinated the antigen for CTA with a great
variation of titer ranging from 1:4 to 1:256, The agglutina­
tion was found weak and the results were very inconsistent. 
This finding raised a new question about the chicken serum: 
a) do chickens have natural agglutinins against histoplasma 
or it is the property of the chicken serum to agglutinate non- 
specifically with antigen used in CTA? and, b) at what age do 
chickens start producing substances which agglutinate CTA
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antigen?
To solve the first question the normal chicken sera 
were heated at 56 C for 30 and 60 minutes and 65 C for 30 
minutes and then tested again. Agglutination was still ob­
served in these heated sera when tested with the CTA method. 
The second problem was investigated by bleeding newly hatched 
normal chickens. The chickens were bled at the age of 6, 24, 
48, and 72 hours, and at 1, 2, 3, 4, 5, 6, 7, 9, and 15 weeks. 
The sera were frozen and were tested later with the CTA method. 
No reaction was observed until the age of 4 weeks, after which 
slight agglutination was observed in the first tube (1:2 dilu­
tion of the serum). This persisted until the 6th week, after 
which some agglutination showed up in the second tube also 
(1:4 dilution). On the 7th week a 1:2 dilution showed defi­
nite agglutination, while slight agglutination was observed 
at a 1:4 and 1:8 dilution. The results were the same up to 
the 15th week when definite agglutination was observed up to 
a 1:4 dilution with a 1:8 dilution showing only slight 
agglutination.
No increase in the CTA titer was observed when sera 
were tested from chickens hyperimmunized against in vivo and 
in vitro grown cells. The same inconsistency was observed 
and the titers varied from 1:16 to 1:256. No noticeable
55
difference was found in the sera from chickens receiving 
different kinds of test antigens. In some instances the titer 
was higher in the serum from initial bleeding prior to first 
injection than in the titer after hyperimmunization. Due to 
these discrepancies the CTA results were inconclusive and 
could not be interpreted.
Higher salt solutions for the dilution of the serum 
were also used, but the results were found to be as incon­
sistent and inconclusive as before. When normal mouse, 
guinea pig and rabbit sera were tested against the test CIA 
antigen, no agglutination was observed.
The presence of precipitins in these chicken sera was 
also investigated. No bands were obtained when the sera from 
hyperimmunized chickens were tested against histoplasmin 
antigen by Ouchterlony plate method and micro-0 uchterlony slide 
method. Some workers (4, 21, 63) reported that higher pre­
cipitin titers were obtained by using higher salt concentra­
tions in the diluent. Salt concentrations from 8-18% have 
been recommended in the literature (4, 63), No success was 
achieved by using higher salt concentrations in Ouchterlony 
diffusion methods. By micro-Ouchterlony technique in one 
instance light bands were obtained with one normal and three 
immune chicken sera with the use of 8% salt in the agar.
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These bands could be due to precipitation of the serum pro­
teins because high salt concentration was used and the bands 
appeared after one week.
Immunoelectrophoresis results were also negative 
even when the slides were bathed in 5, 8, 10, and 15% salt 
solution as recommended by Benedict (A),
Capillary precipitation tests were also attempted 
using the method described by Salvin (47). Slight precipi­
tation was observed in the first 3 tubes of normal as well 
as immune sera when the capillary tubes were refrigerated 
overnight. Higher salt concentrations for the diluent did 
not give any better results.
Wolfe (65, 66) reported a strange phenomenon in the 
chicken precipitin titers. He observed that the precipitin 
titer increased considerably if the serum was left in the 
refrigerator for 7-10 days. No improvement was observed in 
this study when the immune chicken sera were left in the 
refrigerator for the recommended period and then tested.
Tube agglutination was found to be unsuccessful in 
differentiating between the titers of normal and hyperimmu­
nized chicken sera. Normal as well as hyperimmune sera gave 
agglutination up to the second or third tube (1:5 - 1:20 
dilution). Incubation at different temperatures and times
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did not help in the results,
In vivo grown cells also were compared with vitro 
grown cells by the tube agglutination method using known 
immune rabbit serum against H. capsulatum. Different times 
and temperatures were tested. The results showed less 
agglutination in the in vivo grown cells than in in vitro 
grown cells. This could be due to the presence of egg pro­
teins in the suspension of ^  vivo cells or due to the loss 
of some antigenic properties of the yeast cells during the 
process of ether separation.
The results of immunological and serological studies 
did not lead to any definitive conclusions. Although morpho­
logical differences of ^  vivo and vitro grown cells are 
quite evident and also significant, the differences in anti­
genicity of the two kinds are still to be revealed. Presence 
of giant cells makes the situation especially interesting 
and one wonders if these large forms would have some signifi­
cance in pathogenicity and antigenicity or in the progressive 
chronic nature of the disease. A further extensive study is 
required to find out the difference in pathogenicity and 
antigenicity between vivo grown cells and vitro grown 
cells. The use of other animals and further purification of 
the ether harvested cells could be helpful in these studies.
CHAPTER IV
SUMMARY
Two methods, chamber implantation and yolk-sac inocu­
lation of chicken embryo, were employed to grow Histoplasma 
capsulatum for studies of growth characteristics and differ­
entiation of ^  vivo and iji vitro grown cells .
No significant increase in cell numbers was obtained 
when yeast cells of H. capsulatum were placed in the diffusion 
chambers implanted in the peritoneal cavities of mice. The 
decrease in the number of viable cells was rapid, and the 
different test suspending fluids for the yeast cells had 
little effect on the maintenance of viability. Significantly, 
some of the cells when recovered from chambers 12 weeks after 
implantation were still viable. Large forms of the yeast 
cells with thick cell walls were obtained 2-4 weeks after 
implantation. This is one possible explanation for mainten­
ance of viability by organisms for such a long time. The 
inability of the organisms to reproduce inside the implanted 
chamber can be attributed to two possible factors: cell-free 
environments of the chamber, and the formation of gelatinous 
tough clot inside and around the chamber which could stop
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free exchange of peritoneal fluid through the millipore dif­
fusion membrane.
Yolk sac of chicken embryo was found to be an excel­
lent site for the growth of H. capsulatum. Studies on the 
effect of temperature on the growth showed that 37 C tempera­
ture was required to grow yeast phase in the yolk sac. The 
growth was found to be lethal to the embryo and most of the 
embryos died within 5-7 days after inoculation. The death 
rate was found to be directly proportional to the dose of 
inoculum of H. capsulatum yeast cells; the greater the inocu­
lum, the faster was the death rate.
When the yolk and yolk sac of the infected eggs were 
harvested, ground in an Omni mixer and dilutions plated, the 
maximum number of viable cells was obtained 5-7 days after 
inoculation. After this the viability started decreasing 
slowly.
A modified ethyl-ether-water interface system was 
worked out for the separation of the yeast cells from the 
yolk and yolk sac suspension. When the yolk and yolk sac 
suspension was made on O.lM citric acid phosphate or acetic 
acid acetate buffer of pH 4.5 and was shaken with ethyl 
ether, a complex physical system resulted in such a way that 
the yeast cells remained in the aqueous portion, almost in
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pure form.
Morphological studies revealed significant differ­
ences between the sizes of vivo and in vitro grown cells.
Infected yolk sac smears were made at different intervals and
a special method was developed to stain these smears. The 
data obtained from the measurement of cells on 5, 10, 14 and 
17 days on stained smears and in the ether harvested suspen­
sion were compared with the in vitro grown cells on blood 
agar for the same periods. ^  vivo grown cells increased in
size considerably and giant cells were found commonly 10 to 
17 days after inoculation. It was found that the average
cell size was proportional to the period of incubation.
Average cell size as well as the majority of cell population 
shifted toward the larger size range on the increase of incu­
bation period. The giant cells had a typical thick cell wall 
and some characteristics similar to those of H. duboisii. A 
possible relationship of the so-called two species is dis­
cussed .
Chickens were used for immunological studies of the 
in vivo cells. It was found that normal chicken serum will 
agglutinate antigen for CTA nonspecifically and thus no dif­
ferentiation between normal and hyperimmune chicken serum 
could be established. No success was achieved when capillary
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tube agglutination, tube agglutination, precipitation and 
ininiunoelectrophoresis procedures were employed to assay for 
presence of antibodies in the sera of injected and hyperimmu­
nized animals. Due to discrepancies of the immunological and 
serological results, no satisfactory comparison of vivo 
and ^  vitro grown cells could be made at this point and fur­
ther studies are required.
Table 1. Total Counts and Viable Counts Obtained from Chambers 
Using Physiological Saline Containing 1% Normal Mouse 
Serum
Number of Total Number
Time after Chambers of Yeast Total Viable %



















2 days 2 1.4 X 107 1.4 X 10^ 10
3 days 2 1.5 X 107 1.9 X 10^ 13
5 days 2 7.5 X 106 6.0 X 105 8
7 days 2 9.5 X 106 2.9 X 105 3
2 weeks 2 6.0 X 10^ 7,7 X loj 1
3 weeks 2 6.2 X 10^ 3.2 X 10^ < 1
ONN5
Table 2. Total Counts and Viable Counts Obtained from Chambers Using 































2 days 2 1.8 X 10^ 4.6 X 10^ 25
7 days 2 2.7 X 1Q6 - -
10 days 2 6.8 X 107 3.4 X 10^ 5
* 0 day - 1.0 X “ 7 3.8 X io9 381 day 2 1.4 X 10^ 4.3 X 10^ 31
2 days 2 2.0 X 107 5.4 X 106 27
3 days 2 2.2 X 10^ 4.6 X 10^ 21
5 days 2 1.9 X 10? 2.1 X 106 11
7 days 2 8.7 X 10° 5.2 X io5 610 days 2 1.8 X 10^ 5.5 X 10° 3
2 weeks 2 6.2 X 10^ 3.1 X 10^ <1
3 weeks 1 6.8 X 10^ 4.2 X 10^ <1
* Same experiment repeated.
Table 3. Total Counts and Viable Counts Obtained from













0 day - 1.0 X 107 7.1 X 10® 711 day 2 1.1 X 10^ 6.4 X 10° 58
2 days 2 1.3 X 107 3.6 X loO 28
3 days 2 1.5 X 10^ 2.3 X lo! 15
5 days 2 1.4 X 10^ 2.1 X 10^ 14
7 days 2 1.7 X 10^ 2.1 X 10° 7
2 weeks 2 9.8 X 10^ 1.8 X 10^ 2
3 weeks 2 8.0 X 106 7.0 X 10^ 1
4 weeks 2 2.6 X 10^ 1,8 X 10^ < 1
8 weeks 2 2.8 X 10^ 1.8 X 10^ <1
12 weeks 2 1.4 X 10^ 1.0 X 10^ <1
Table 4. Total Counts and Viable Counts Obtained from Chambers 
Using Tyrode's Solution Containing 1% Normal Mouse 
Serum
Number of Total Number
Time after Chambers of Yeast Total Viable %
Implantation Recovered Cells/chamber Cells/chamber Viability
0 day - 1.0 X 107 5.8 X 10^ 58
1 day 2 1.2 X 107 - z: -2 days 2 1.5 X 10 7 5.4 X “ ft 363 days 2 1.6 X 10^ 4.3 X ’■“ft 275 days 2 2.6 X 107 4.7 X 10° 18
7 days 2 1.2 X “ ft 1.2 X 10° 102 weeks 2 6.2 X 10^ 5.0 X 10^ 8
3 weeks 2 7.1 X 10° 1.4 X 10^ 2
4 weeks 2 5.0 X 10^ 1.3 X 10^ 2.5
6 weeks 2 5.3 X 10^ 7.3 X 103 41
8 weeks 2 6.0 X lof 4.8 X 102 41
12 weeks 2 8.7 X 10^ 1.1 X 10^ <1
U1
Table 5. Total Counts and Viable Counts from Chambers Using Eagle's Medium
Time Number of Total Number
after Chambers of Yeast Total Viable 7o
Implantation Recovered Cells/Chamber Cells/Chamber Viability
0 day - 1.0 X 107 4.2 X 10^ 42
1 day - - - -
2 days 2 2.1 X 10^ 5.0 X 10^ 25
3 days 2 4.0 X 10^ 9.6 X 10° 24
5 days 2 4.5 X 10^ 8.1 X 18
7 days 2 2.3 X 10^ 2.3 X 10° 10
10 days 2 1.3 X 107 1.4 X 10^ 11
2 weeks 2 1.4 X 1Q7 7.0 X 10, 5
3 weeks 2 8.0 X 10^ 7.4 X 10^ <1
* 0 day - 1.3 X 10^ 4.5 X 10^ 36
1 day 2 2.3 X lof 5.2 X 10^ 23
2 days 2 2.3 X 10^ 4.6 X 10^ 20
3 days 2 3.9 X 10^ 4.5 X 105 11
5 days 2 3.5 X 10^ 6.1 X lof 18
7 days 2 2.3 X 10^ 2.7 X 10^ 12
10 days 2 1.3 X 10^ 2.4 X 10^ <2
3 weeks 2 2.5 X 10^ 2.0 X 10^ <1
4 weeks 1 2.0 X 10° 8.0 X 10^ <1
6 weeks 1 9.1 X 10^ 3.0 X 103 <1
o\
Same experiment repeated,
Table 6, Effect of Dose of Histoplasma capsulatum Yeast Cells on the 







Percent of Embryos Dead at Each Interval Number of 
Embryos 
Hatched3 day 5 day 7 day 10 day 12 day 14 day
3.5 X 10® 61 21.3 57.4 82.0 96.7 100 - -
1.0 X 10® 151 22.5 54.3 82.1 96.0 100 - -
5.0 X 10^ 165 13.3 40.0 81.8 95.1 100 - -
5.0 X 10^ 127 12.6 31.5 66.9 88.2 96.9 99.2 0.8
5.0 X 10^ 58 10.3 24.1 55.1 84.4 93.0 93.0 7
5.0 X 10^ 42 11.9 21.4 42.8 69.0 83.3 88.1 11.9
Control 42 7.1 16.6 23.7 35.7 42.8 47.6 52.4
cr>
Table 7, Number of Viable Cells of H. capsulatum Obtained
from Yolk and Yolk Sac at Different Intervals
Average Total Average Total Number Average
Number of Cells Viable Cells Days after of Eggs Viable Cells
Inoculâted/Egg Inoculated/Egg Inoculation Harvested Harvested/Egg
1 X 10' 4.4 X 10' 3 56 3.40 X 107
5 56 2.86 X 10®
7 54 8.50 X 10®
10 52 1.54 X 10®
14 47 9.60 X 10^
00









of Cells in Each Size Group






















A 3 3.15 0 32 58 10 0 0 0 0 0 0 0 0 0
5 3.17 5 44 40 11 0 0 0 0 0 0 0 0 0
10 3,65 2 34 36 14 10 3 1 0 0 0 0 0 0
14 3.72 0 33 37 19 7 3 0 1 0 0 0 0 0
17 3.77 1 29 30 25 9 2 1 1 1 1 0 0 0
B 5 3.6 1 21 39 35 1 3 0 0 0 0 0 0 0
10 4.82 0 3 26 36 13 12 3 5 0 1 0 1 0
C 5 3,95 0 4 50 39 6 1 0 0 0 0 0 0 0
10 4.83 0 2 23 48 10 10 1 1 I 3 0 1 0
14 5.06 0 2 22 43 15 9 1 I I 3 I 2 0
17
(Hatched)
6.0 0 3 19 28 13 9 7 8 3 3 3 3 1
ONVO
* Diameter of the long axis.
** A - In vitro grown cells, formalin killed, ether treated, wet mount,
B - ^  vivo grown cells, formalin killed, harvested with ether, wet mount, 
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O
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3 5  7  10 12 14 H
5 x 1 0 ^ /egg
3  5  7 10 12 14 H
Control
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DAYS A F T E R  IN O C U L A T IO N  
F i g u r e s *  N um ber o f  v iab le  c e l l s  of H Is to p lo sm o  c o p eu lo tu m  o b ta in ed  f ro m  yolk and yolk s a c  o t  different in te rv a ls .
o  ■ o  IN VIVO GROWN,YOLK SAC SMEAR. STAINED
ù-----------ù  IN VIVO GROWN. E TH ER  HARVESTED. WET MOUNT
O . --------O  IN VITRO GROWN. ETHER TREA TED. WET MOUNT
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F ig u re  4 .  In c re a se  in cell s i z e .  Average s ize  of H is to p lasm o  c o p su lo tu m  y e a s t  c e l ls  o t  d i f fe re n t  I n te rv o l s .
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IN VIVO GROW N. YOLK SA C S M E A R , ST A IN E D  
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IN VITRO G R O W N ,E T H E R  T R E A T E D  , W E T  MOUNT
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□ 20 C -  17 d o y s  o f f e r  i n o c u la t i o n
13.14 14-191-2 11-124 - 3 7 -8 0-9 9-100-1 5-6 6 -72-3
S I Z E  IN  M IC R O N S  
F i g u r e s .  S iz e  d i s t r ib u t io n  o f  H Is to p lo sm o  co p su lo tu m  y e o s t  c e l l s  o t  d i f f e r e n t  I n t e r v o l s .
75
»? «I >TT
P l a t e  1 - H i s t o p l a s m a  c a p su la tv im  y e a s t  c e l l s  g ro w n  in  y o lk  s a c  f o r  
d i f f e r e n t  i n t e r v a l s .  1 - In  v i t r o  g r o w n  3 d a y  o ld  c e l l s ,  e t h e r  t r e a t e d  
(w e t  m o u n t ) .  2 - G ro w n  in  y o lk  s a c ,  e t h e r  h a r v e s t e d  10 d a y s  a f t e r  
i n o c u l a t i o n  (w e t  m o u n t) .  2A - A  s in g l e  c e l l  f r o m  th e  s a m e  p r e p a r a ­
t io n ,  e n l a r g e d  to  s h o w  d o u b le  c o n t o u r e d  c e l l  w a l l .  3 - I n f e c t e d  yolk  
s a c  s m e a r ,  5 d a y s  a f t e r  i n o c u l a t i o n  ( s p e c i a l  c r y s t a l  v i o l e t  s ta in in g ) .
4 - I n f e c t e d  y o lk  s a c  s m e a r ,  10 d a y s  a f t e r  in o c u la t io n ,  c e l l s  w i th  
p r o m i n e n t  h a lo  a n d  th ic k  c e l l  w a l l  ( s p e c i a l  c r y s t a l  v i o le t  s ta in in g ) .
5 - I n f e c t e d  y o lk  s a c  s m e a r  14 d a y s  a f t e r  in o c u la t io n  ( m e t h a n a m in e  
s i l v e r  s t a in in g ) .  6 - I n f e c te d  y o lk  s a c  s m e a r ,  17 d a y s  a f t e r  i n o c u l a ­
t io n  ( s p e c i a l  c r y s t a l  v io le t  s t a in in g ) .
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